Where do Solid Biosciences Inc.'s ratios come from?

Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-109.9%-15.3pp	-94.6%-37.8pp	-56.8%-15.8pp	-41%+1.5pp
Return on invested capital	-161.1%+1.1pp	-162.2%-34.8pp	-127.5%-6.6pp	-120.8%—
Liquidity
Current ratio	6.1×+0.9×	5.2×-3.7×	8.9×-0.8×	9.8×+0.3×
Leverage
Debt-to-equity	0.1×-0.1×	0.2×0.0×	0.2×+0.1×	0.1×+0.1×
Per Share
Book value per share	$2.06-38.8%	$3.36-47.1%	$6.36-74.4%	$24.87-15.0%
Valuation
Market capitalization	$910.66M+145%	$159.82M+29.0%	$123.89M+17.9%	$105.06M-45.6%
Price / book	2.4×+1.2×	1.2×+0.2×	1×+0.5×	0.5×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Solid Biosciences Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Solid Biosciences Inc.'s ratios come from?: Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.